RevAge Mesenchymal Stem Cells (MSCs) are derived from ethically sourced human umbilical cord tissue and are developed for advanced regenerative applications. These cells demonstrate strong regenerative, anti-inflammatory, and immunomodulatory properties.
MSCs possess the unique ability to migrate to injured tissues, promote cellular repair, reduce inflammation, and support long-term tissue regeneration, making them highly suitable for cardiovascular and regenerative medicine applications.
How MSCs contribute to tissue repair and regeneration
MSCs migrate to damaged tissues in response to inflammatory signals.
Supports myocardial regeneration and improves cardiac function.
Reduces inflammatory responses and tissue damage.
Secretes growth factors that promote healing and angiogenesis.
RevAge MSC therapy is under continuous development with emphasis on safety, scalability, regulatory compliance, and clinical translation.
Extensive in-vitro and in-vivo evaluations.
Standardized GMP-aligned production processes.
Prepared for controlled clinical investigations.
Collaborate with us to advance mesenchymal stem cell therapy and innovative regenerative medicine solutions.
Become a Research Partner